Alan S. Roemer is Director of NexImmune, Inc.. Currently has a direct ownership of 0 shares of NEXI, which is worth approximately $0. The most recent transaction as insider was on Nov 22, 2023, when has been sold 3,992 shares (Common Stock) at a price of $1.94 per share, resulting in proceeds of $7,744. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Alan S. Roemer Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 22 2023
SELL
Open market or private sale
$7,744 $1.94 p/Share
3,992 Reduced 100.0%
0 Common Stock
Nov 21 2023
SELL
Open market or private sale
$8,279 $2.16 p/Share
3,833 Reduced 48.98%
3,992 Common Stock
Dec 21 2021
BUY
Exercise of conversion of derivative security
$209,737 $3.1 p/Share
67,657 Added 25.7%
195,641 Common Stock
Feb 17 2021
BUY
Conversion of derivative security
-
127,984 Added 50.0%
127,984 Common Stock

Also insider at

INAB
IN8BIO, INC. Healthcare
ASR

Alan S. Roemer

Director
New York, NY

Track Institutional and Insider Activities on NEXI

Follow NexImmune, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NEXI shares.

Notify only if

Insider Trading

Get notified when an Nex Immune, Inc. insider buys or sells NEXI shares.

Notify only if

News

Receive news related to NexImmune, Inc.

Track Activities on NEXI